Navigation Links
EtQ’s Chief Technology Officer to Speak at INTERPHEX
Date:4/16/2013

Farmingdale, NY (PRWEB) April 16, 2013

EtQ is pleased to announce that its CTO, Morgan Palmer, will be speaking at INTERPHEX, to be held from April 23st to 25th in New York, NY.

Palmer will present the topic, “Establishing a Quality Agreement with a Unified Approach for all Suppliers,” at 10:15 am on Wednesday, April 24th.

“It is important to understand the various elements that can arise as a result of poor supply chain quality,” stated Palmer. “This session will explain these elements and will discuss the benefits of extending the quality system to suppliers, such as real-time risk management in the supply chain. Ultimately, what attendees will take away from this session is an understanding of the need for harmonizing quality agreements for suppliers as well as the best practices in extending the quality system to the supply chain.”

EtQ will also be exhibiting at INTERPHEX. For more information, visit us in booth 1861, or on the Web at http://www.etq.com. In addition, EtQ is offering a 50 percent discount on conference registration. Register here to receive this discount on either one- or two-day conference packages. This will provide access to all INTERPHEX Conference sessions including keynotes, technical workshops, special Thursday presentations, lunch on Tuesday and/or Wednesday as well as access to the show floor.

About INTERPHEX
INTERPHEX is the leading annual pharmaceutical and biopharmaceutical trade show. Key decision makers find the networking opportunities, products, services and information they need to ensure quality and maximize efficiency, agility, and flexibility that solve manufacturing and supply chain problems. INTERPHEX is where intelligence and passion intersect with the full spectrum of industry products and services to create new insights and innovation.

About EtQ
EtQ is the leading FDA Compliance, Quality, EHS, and Operational Risk Management software provider for identifying, mitigating and preventing high-risk events through integration, automation and collaboration. Founded in 1992, EtQ has always had a unique knowledge of FDA Compliance, Quality, EHS, and Operational Risk processes, and strives to make overall quality operations and management systems better for businesses. EtQ is headquartered in Farmingdale, NY, with main offices located in EMEA, the UK, and Arizona. EtQ has been providing software solutions to a variety of markets for more than 20 years. For more information, please visit http://www.etq.com or contact us at 800-354-4476.

EtQ is a trademark of EtQ Management Consultants, Inc. All other product names and company names are trademarks or registered trademarks of their respective owners.

Read the full story at http://www.prweb.com/releases/2013/4/prweb10633650.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related biology technology :

1. Veracyte Announces Appointment of Shelly D. Guyer as Chief Financial Officer
2. PI hires William Culpi as Engineering Chief - PI miCos USA Products by PI USA
3. GenoSpace Expands Its Management Team by Appointing Daniel Meyer as Chief Financial Officer
4. CardioWise™ Welcomes Geoffrey Dalbow as Chief Technology Officer
5. DuPont Joins Israel’s Office of the Chief Scientist Global Enterprise R&D Cooperation Framework
6. Clinical Immunology Society Appoints Vincent Bonagura, MD as Editor-in-Chief of the Journal of Clinical Immunology
7. Elsevier Names Dr. Jim Nolin Editor-in-Chief of Order Set Solution
8. Janet Kreizman Appointed Chief Executive Officer of AACC
9. Lou Paradise, President and Chief of Research, Topical BioMedics, Inc. Slated to Speak at Integrative Healthcare Symposium
10. Inflamax Research Appoints Dr. Anne Marie Salapatek President & Chief Scientific Officer
11. ABIA Hires Biomedical Executive, Serial Entrepreneur as Chief Operating Officer
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/8/2016)... ... December 08, 2016 , ... ... control cells — optogenetics — is key to exciting advances in the study ... spatially patterned light projected via free-space optics stimulates small, transparent organisms and excites ...
(Date:12/8/2016)... Mass (PRWEB) , ... December 08, 2016 , ... ... genetic data bioInformatics portal. In response to client demand KbioBox developed a sophisticated ... edit biodesign program. Both are accessible from KBioBox’s new website, https://www.kbiobox.com/ ...
(Date:12/8/2016)... Soligenix, Inc. (OTCQB: SNGX) (Soligenix or the ... commercializing products to treat rare diseases where there is ... be hosting an Investor Webcast Event Friday, December 16, ... innate defense regulators (IDRs) as a new drug class, ... the recently announced and published Phase 2 clinical data ...
(Date:12/8/2016)... 2016   Biocept, Inc . (NASDAQ: ... clinically actionable liquid biopsy tests to improve the ... featuring its Target Selector™ Circulating Tumor Cell platform ... detection of actionable biomarkers in patients with metastatic ... Sara Cannon Research Institute (SCRI), the research arm ...
Breaking Biology Technology:
(Date:12/5/2016)... 5, 2016  The Office of Justice Programs, ... CT Scans Enhance or Replace Medico Legal Autopsies?" ... supporting or replacing forensic autopsies with postmortem X-ray ... In response to recommendations made by The ... CT scans as a potential component of medicolegal ...
(Date:11/29/2016)... 2016 BioDirection, a privately held medical device ... objective detection of concussion and other traumatic brain injury ... a meeting with the U.S. Food and Drug Administration ... Package. During the meeting company representatives reviewed plans for ... to commencement of a planned pilot trial. ...
(Date:11/22/2016)... 22, 2016 According to the new market research ... Face, Vein, Signature, Voice), Multi-Factor), Component (Hardware and Software), Function (Contact and ... the market is expected to grow from USD 10.74 Billion in 2015 ... between 2016 and 2022. Continue Reading ... ...
Breaking Biology News(10 mins):